GRAL GRAIL, Inc. Common Stock Loading...

From DGX earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
08:30
Feb 10 ◎
Jim Davis Chairman, CEO and President, Quest Diagnostics Incorporated DGX Q4 FY25 call
Quest provides phlebotomy logistics for Grail's multi-cancer early detection test, representing a modest but growing revenue stream and validating Grail's clinical deployment.
GRAL
HIGH

About GRAL Analyst Coverage

Buzzberg tracks GRAL (GRAIL, Inc. Common Stock) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Jim Davis.